1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated with reduced clinical fractures in postmenopausal patients with osteoporosis. 2. ...
1. Among a large cohort of Danish adults, the use of potent or very potent topical corticosteroids was found to ...
1. In this retrospective cohort study, the risk of an atypical fracture increased with longer duration of bisphosphonate use while ...
1. Delayed subsequent denosumab doses were shown to increase the risk for vertebral fractures compared to on-time injection. 2. There ...
1. In this observational study, patients who received one of three direct oral anticoagulants (DOACs) were significantly less likely to ...
![Statin therapy does not prevent osteoporotic fractures [JUPITER trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/osteoporosis-e1417474828821-350x250.jpg)
Effect of Early Surgery vs Physical Therapy on Knee Function Among Patients With Nonobstructive Meniscal Tears: The ESCAPE Randomized Clinical ...
1. In postmenopausal osteoporotic women at high risk for fracture, romosozumab followed by alendronate significantly reduced fracture risk compared to ...
1. While osteoporosis medications may have some benefits in chronic kidney disease patients (CKD), the evidence is unclear with respect ...
1. Based on a cross-sectional study, children and adolescents who reported using stimulant medications were found to have lower bone ...
1. Abaloparatide significantly reduced the risk of new vertebral and non-vertebral fractures compared with placebo. 2. Treatment with abaloparatide also ...
